All News #Library
Biotech
Stuart Therapeutics Reports Initial Ph 3 for ST-100 in Dry Eye
24 Jun 2025 //
PR NEWSWIRE
Stuart Announces First Patient, First Visit in Phase 3 Trial of Vezocolmitide
29 Dec 2023 //
PR NEWSWIRE
Stuart announces, expansion of development pipeline, additions to Advisory Board
09 Jan 2023 //
PR NEWSWIRE

Market Place
Sourcing Support